Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has again been named a Derwent Top 100 Global Innovator by Clarivate Analytics. Clarivate Analytics' Top 100 Global Innovators Report identifies the world's most innovative organizations, assessing each one on its ability to successfully develop valuable patented inventions that also have strong commercialization potential based on 
The study "CardioSecur® in the preclinical setting - When time does matter" of the University of Heidelberg confirms the advantages of the mobile ECG in acute cases. This was demonstrated by applying CardioSecur during a period of more than 7 months in ambulances in the area of Heidelberg, Germany. 
BIOTRONIK has announced first enrollment in a multicenter study that aims to demonstrate that a two-lead cardiac resynchronization therapy (CRT) system with atrial sensing is at least as effective as a conventional three-lead system. BIOTRONIK's CRT-DX technology provides therapy through two ventricular leads and features a floating dipole for complete atrial diagnostics without an additional lead. 
A network of NHS transformation professionals has launched to support NHS and private healthcare providers in improving the safety, effectiveness and experience of care. Called Transforming Healthcare Consultancy (THC), the team of individual specialists will provide health service improvement, change management and digital transformation services. 
Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public disease awareness and providing more accessible healthcare services via digital platforms in China, by leveraging the company's scientific leadership and expertise combined with Tencent's leading technology in the fields of internet and artificial intelligence. 
Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMSWe have, of course, but this plan is still of interest and welcome. I think everybody would be very surprised if itwere to last ten-years, but it’s good to have a clearly articulated vision for the service and where the technology should go.